The Oncology Institute, Inc. (TOI) Financial Analysis & Valuation | Quarter Chart
The Oncology Institute, Inc. (TOI)
TOIPrice: $3.15
Fair Value: 🔒
🔒score
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. ... more
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United ... more
Description
Shares
| Market Cap | $311.84M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Daniel Virnich |
| IPO Date | 2020-06-04 | CAGR | 0.24% |
| Employees | 825 | Website | theoncologyinstitute.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TOI chart loading...
Fundamentals
Technicals
| Enterprise Value | $3.60B | P/E Ratio | -5.29 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.62 | P/B Ratio | -203.62 |
| P/CF Ratio | -130.19 | P/FCF Ratio | -11.22 |
| EPS | $-0.67 | EPS Growth 1Y | -23.94% |
| EPS Growth 3Y | 6406.02% | EPS Growth 5Y | -74.02% |
| Revenue Growth 1Y | 27.79% | Gross Margin | 0.14% |
| Operating Margin | -0.07% | Profit Margin | -0.12% |
| ROE | 7.6% | ROA | -0.37% |
| ROCE | -0.39% | Current Ratio | 1.59 |
| Quick Ratio | 1.35 | Cash Ratio | 0.47 |
| Debt/Equity | -1.67 | Interest Coverage | -3.2 |
| Altman Z Score | 1.42 | Piotroski Score | 3 |